Comparison of <sup>18</sup>F-Choline PET/CT and <sup>99m</sup>Tc-Sestamibi SPECT/CT in the Localization of Hyperactive Parathyroid Glands in Primary Hyperparathyroidism: Diagnostic Performance in Discordant Cases.

Front Endocrinol (Lausanne) · 2025 · PMC12658743 · PMID 41323977

Europe PMC DOI

hedged sentences

0.0980

closest p · 2.0× alpha

0.0980

boldest claim

The sentences

did not reach statistical significancep=0.098so close (0.05 < p ≤ 0.1)

Although these differences did not reach statistical significance (p=0.098), the trend suggests a possible association between cellular composition and imaging performance.

also in 111,027 other papers

showed a trendno p-value reported

Conclusion FCH PET/CT showed a trend toward improved diagnostic performance and postoperative cure compared with MIBI SPECT/CT in discordant cases.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Comparison of &lt;sup&gt;18&lt;/sup&gt;F-Choline PET/CT and &lt;sup&gt;99m&lt;/sup&gt;Tc-Sestamibi SPECT/CT in the Localization of Hyperactive Parathyroid Glands in Primary Hyperparathyroidism: Diagnostic Performance in Discordant Cases.

The sentences

Comparison of <sup>18</sup>F-Choline PET/CT and <sup>99m</sup>Tc-Sestamibi SPECT/CT in the Localization of Hyperactive Parathyroid Glands in Primary Hyperparathyroidism: Diagnostic Performance in Discordant Cases.